The data collected thus far shows the effectiveness of the clinical pathway in reducing time taken to administer the first antibiotic treatment for peritonitis patients presenting to ED in our local facility. Despite the limitation of this analysis including a small number of patients, the possibility of introducing a "sepsis kill" program in ED and short monitoring period, this will be the ongoing direction for the author's team to work on to evaluate the sustainability of the clinical pathway